According to ESPN’s informants, Chris Sale and the Atlanta Braves have finalized a single-year, $27 million contract prolongation, which incorporates a team option. This arrangement ensures the potential Hall of Fame pitcher will not enter free agency next winter.
Sale, slated to turn 37 on March 30, revitalized his professional journey with the Braves subsequent to five seasons plagued by injuries. He clinched the National League Cy Young Award in 2024, which was then succeeded by a robust performance in 2025.
This pact, which appends an extra year to his ongoing commitment and features a $30 million option devoid of a buyout for the 2028 season, signifies the most substantial single-season compensation the Braves have ever assured an individual.
The Braves solidified Sale’s presence subsequent to springtime ailments impacting their emerging starters, Spencer Schwellenbach and Hurston Waldrep. These physical setbacks are poised to test the team’s reserves as they endeavor to rebound from a lackluster 76-86 campaign in 2025.
Sale emerged as one of the scant positive aspects for the Braves; however, a rib ailment curtailed him to 125⅔ innings. During this period, he recorded a 2.58 ERA, fanning 165 opposing batters while issuing merely 32 walks.
As he steps into his 17th major league campaign, Sale has stood out as one of his generation’s most formidable hurlers, boasting a lifetime ERA of 3.01 across 2,084 innings, accompanied by 2,579 strikeouts and 487 bases on balls. His four-seamer, persistently registering around 95 mph and occasionally hitting 99, augments one of the sport’s most destructive sliders, allowing Sale to preserve an impressive repertoire well into his career and continue perplexing batters as a 6-foot-6, 180-pound mystery.
This agreement represents the second contract extension Sale has finalized with the Atlanta club, the initial one having materialized after the December 30, 2023, transfer from the Boston Red Sox. Sale had initially joined Boston through a highly publicized exchange with the Chicago White Sox in December 2016, showcasing exceptional talent during his first two Red Sox seasons, including 308 strikeouts in his Boston inaugural year, followed by clinching a World Series championship twelve months later.
Soon after, a series of physical afflictions began to trouble Sale. He contended with challenges in 2019, then underwent Tommy John surgery during the apex of the COVID-19 pandemic, leading him to miss the entire 2020 season. He returned to commence nine games in 2021, only to be sidelined for all but two starts in 2022 after enduring a fractured rib cage, a pinky finger broken by a line drive, and a right wrist fracture from a bicycle incident.
Despite commencing 20 games in 2023, Sale’s inclination to concede home runs presented him as a reduced iteration of the formidable pitcher who, in his initial seven campaigns as a regular starter, amassed a 99-59 record with a 2.91 ERA across 1,388 innings.
Upon arriving in Atlanta and regaining his full health, Sale unearthed his optimal form. After consistently ranking within the top six in Cy Young balloting during each of those seven prior seasons, he at last secured the prestigious award for the first time, achieving an 18-3 record, a 2.38 ERA, and a National League-leading 225 strikeouts across 177⅔ innings.
The Braves saw prompt vindication for the biennial, $38 million contract they had offered him, spanning the 2024 and 2025 seasons. This agreement also encompassed a $16 million team option, which they chose to activate for the current year.
This recent prolongation withdraws one of the premier talents from a market potentially influenced by a labor stoppage, thus preventing Sale from entering free agency for the initial time in his career. He has now put his signature on four contract prolongations: one individually with the White Sox and Red Sox, and two with the Atlanta organization.